They will do this wrong and not compare it to other soft walking exosuits. Which means followup research will need to be done. They are afraid of comparisons, which means the president of this company does not trust their product to win a competition like that.
Israel’s ReWalk turns focus to stroke victims with cheaper walking device
Nasdaq-listed firm starts a clinical study of new ReStore soft suit, successor to its exoskeleton for paraplegics
ReWalk's new product, the ReStore soft suit to help rehabilitate stroke victims (Courtesy)
ReWalk Robotics Ltd., the Israeli developer of a robotic
exoskeleton system that helps the paralyzed to walk, has started a
clinical study of a new product that will aid the rehabilitation of
people who have suffered a stroke.
The company said that a first study participant began using a new “soft exo-suit system,” the ReStore, which is meant to rehabilitate individuals with lower limb disability due to stroke. The patient was at the Spaulding Rehabilitation Hospital in Boston, Massachusetts, where the study is being led by a team of researchers from the Boston University College of Health and Rehabilitation Sciences: Sargent College.
The study seeks to enroll 40 participants at five of the top rehabilitation hospitals in the US, the company said in a statement last week.
The company said that a first study participant began using a new “soft exo-suit system,” the ReStore, which is meant to rehabilitate individuals with lower limb disability due to stroke. The patient was at the Spaulding Rehabilitation Hospital in Boston, Massachusetts, where the study is being led by a team of researchers from the Boston University College of Health and Rehabilitation Sciences: Sargent College.
The study seeks to enroll 40 participants at five of the top rehabilitation hospitals in the US, the company said in a statement last week.
No comments:
Post a Comment